Drugs
‘Host Christine Dolan speaks with Angelia Desselle on the life-altering health problems she experiences after taking the Pfizer ‘vaccine’. Desselle also details the absolute lack of help from the government, or drug companies.’
‘Data released today by the Centers for Disease Control and Prevention (CDC) showed that between Dec. 14, 2020 and Aug. 20, 2021, a total of 623,343 total adverse events were reported to VAERS, including 13,627 deaths — an increase of 559 over the data released last week.’https://childrenshealthdefense.org/defender/vaers-cdc-covid-vaccine-injury-reports-jump-27000-one-week/?utm_source=salsa&eType=EmailBlastContent&eId=d97237de-241f-4593-a2c9-0c36197c3471
‘The question I get more than any other:
I had Covid. I had an antibody test to prove it. Am I protected (and do I need to get the vaccine)?
Let me start with the usual disclaimer: THIS IS NOT MEDICAL ADVICE. I AM NOT A PHYSICIAN.
But the answer is now increasingly clear: natural immunity from Covid following infection and recovery is HIGHLY protective against future Covid infections. Rates of reinfection are very low.
Perhaps natural immunity eventually wanes, but we don’t know when. In fact, a little-noticed paper from June suggests it may actually strengthen for at least a year – and provide plenty of protection from Delta and other variants.
I am not going into the problems with vaccine-generated protection today or with our political unwillingness to recognize natural immunity. (Remember, GOOD NEWS – we could all use it).
Let’s just look instead at why natural immunity works so well.
You immune response comes in two forms: “humoral” and “cellular.”
When you are infected with Sars-Cov-2, your body’s “B-cells” – part of the immune system – quickly pour out “antibodies.” These antibodies attack the viral particles circulating in your blood and other fluids, hoping to keep the virus from entering your cells and replicating itself.
This is humoral immunity. Your B-cells make antibodies in many different shapes. Some are better at sticking to the virus. Scientists call these “neutralizing” antibodies because they neutralize the “antigen,” the foreign body attacking you, keeping it from entering your cells.
Amazingly, your B-cells quickly figure out which antibodies neutralize most effectively and make more of them, while cutting back on those that don’t work.
At the same time, another part of the immune system – killer or CD8 T-cells – attacks cells that the virus has already infected. You destroy your own cells to prevent the virus from using them to make more copies of itself. This is cellular immunity.
For a few days after you are infected, your immune system is in a race with the virus. If you win the race, defeat the virus, and recover – as the vast majority of people infected with Sars-Cov-2 do – within a week or two you should have no measurable levels of virus in your body.
With no invader provoking a response, your B-cells will stop making antibodies against the virus. Over time, the antibodies you have made will slowly degrade – a change scientists can measure.
Antibody levels are measured as “titers” – how much the part of the blood that contains antibodies must be diluted before it stops neutralizing the coronavirus (or any antigen).
The details of how scientists measure titers are complicated. But the takeaway is simple – higher titers mean more antibodies in the initial sample. Higher titers are better, unless they are so high they indicate an overactive immune response. Over time, titers will decline.
But your immune system has not forgotten the virus. Both B-cells and T-cells are now trained to respond to it, should it reappear. (Confusingly, the immune system includes two types of T-cells, CD4 and CD8, and many subtypes of both B- and T-cells.)
This “adaptive” response explains why people remain immune to some viruses for their entire lives after being infected once – or inoculated with an effective vaccine.
Scientists have different ways to measure your immune response.
They can measure how tightly your antibodies bind to an antigen (the virus), how many different parts of the antigen they attack, how quickly your B- and T-cells will ramp up to make new antibodies or attack infected cells, and even whether those antibodies can recognize new variants of the original antigen.
In June, Rockefeller University researchers published a paper in Nature examining how antibodies changed up to a year after coronavirus infection and recovery.
The authors found that even “in the absence of vaccination, antibody reactivity to the receptor binding domain (RBD) of SARS-Cov-2, neutralizing activity, and the number of RBD-specific memory B-cells remain relatively stable between 6 to 12 months after infection.” (They also found that vaccination of previously infected and recovered people could boost those responses further.)
However, in a second paper published in late July, the authors found that vaccines did NOT produce a similarly powerful response in the B-cells of people who had not previously been infected. (But we’re not going to talk about that today. Good news, remember?)
In July, another group of researchers published similar findings in Cell:
Again, the authors offered reassuring findings:
Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies [have] an extended half-life of >200 days suggesting the generation of longer-lived plasma cells… Taken together, these results suggest that broad and effective immunity may persist long-term in recovered COVID-19 patients.
T-cell immunity was also durable, the authors found, and the killer T-cells could recognize not just the coronavirus’s spike protein but other parts of the virus.
(Again, the paper offered reasons to believe vaccine immunity was inferior, but we won’t talk about that, not today.)
A paper from Israel released Sunday reported that antibody titers in people who had recovered from infection fell only 5 percent a month (titers in the vaccinated fell 40 percent a month, though from a higher baseline).
Even better, between four and nine months after infection, the percentage of people with low titers remained roughly flat, at 10 percent.
Source: https://www.medrxiv.org/content/10.1101/2021.08.19.21262111v1.full
All these papers should increase our confidence that natural immunity is durable and powerful. But what about real-world data?
Fortunately, we now have several studies examining large groups of previously infected people. In perhaps the most striking, the Cleveland Clinic reported in June a reinfection rate of zero among 1,359 people with natural immunity:
Not one of the 1359 previously infected subjects who remained unvaccinated had a SARS-CoV-2 infection over the duration of the study.
Source: https://www.medrxiv.org/content/10.1101/2021.06.01.21258176v2
(The political pressure for vaccination is such that the Cleveland Clinic then issued a press release basically pretending the study didn’t say what it did. But we won’t talk about that today, good news, etc.)
And this week, Israeli researchers looking at a much larger group of people also found very, very low reinfection rates. Only 19 out of 16,215 people with natural immunity had a second infection from June 1 to August 14 (far fewer than the number of vaccinated people who were infected in a matched group).
These findings are particularly important because the Delta variant accounted for nearly all coronavirus infections in Israel by this summer. In other words, natural immunity remained protective against Delta.
Source: https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1.full-text
So there’s your good news. Both the theoretical bench work and the real-world data suggest that natural immunity is long-lasting and protective even against Sars-Cov-2 variants that can evade vaccines.
I’ll leave it to you to decide whether that means you need a vaccine if you have already had and recovered from Covid.’https://alexberenson.substack.com/p/natural-immunity-for-the-win
Here in Australia the politicians continue to push fear of the Wuhan virus with lockdowns and threat of mandatory vaccinations! However, ‘Now that we have had 18 months to “slow the spread” it is time to take stock of the pandemic. We have learned many good things that the media and our pandemic managers rarely report. Most fundamentally, we do not need to be afraid of COVID-19 anymore. The media and some government health authorities are still pushing hysteria and fear, but that should not prevail. Let’s look at the good news that can calm our fears about COVID-19. There’ll be time at a later date to look at the bad and the ugly of the resolving pandemic.
1) Globally, the survival rate for COVID-19 is 99.8%. Under the age of 70, the survival rate for COVID-19 is 99.97%. This is on par with many influenza seasons. Americans younger than 70 do not have to fear COVID-19 any more than influenza and we know how to protect the elderly.
2) Herd immunity for the alpha strain is here. Sixty-seven percent of the American population have had at least one COVID-19 vaccination. The official number of cases is about 10% of the population, but several antibody studies show that the percentage of those with natural immunity is 4-6 times higher. Dr. Marty Makary, a Johns Hopkins professor, estimates that 80-85% of the population is immune from natural immunity and vaccination. Those who deny this must explain how cases and deaths started to decline in January way before there was a significant vaccine effort. COVID-19 will not go away. Instead, we are transitioning now from a pandemic to endemic status and, indeed, some eminent virologists say vaccinating in the middle of a pandemic is making herd immunity more difficult to obtain through the creation of variants.
3) The average age of death from COVID is 78. The average life expectancy in America is 78. This is not to say, “Don’t worry, only old people are dying of COVID-19.” However, this fact should direct and inform our policies to protect the elderly especially. Children and those under age 70 are at much lower risk.
4) Early outpatient treatment should be adopted immediately for COVID-19. Hydroxychloroquine works. Ivermectin works. It has been estimated 85% of COVID-19 deaths could have been prevented were these medicines used early. America’s Frontline Doctors have an excellent compilation of research. The cost of these treatments is $1/day. A new IV treatment, REGEN-COV, has been approved for early use in COVID-19. Don’t wait to see if you will get sick. Treat early.
5) Children are safe from COVID-19 and don’t spread the virus either. A study in the UK showed that the survival rate in children is 99.995%. In the U.S. 335 children have died since the start of the pandemic. A study done by Johns Hopkins and FAIR Health showed that all of the children that died from April 2020 to August 2020 had immune problems or were chronically ill. In that period not one healthy child died. Children have more chance of dying in a car wreck, unintentional drug overdose, or influenza than from COVID-19. Vaccination for healthy children is not needed.
6) Sweden did not have a lockdown or mask mandate and did better with cases and deaths than many countries. Lockdown did not work and had serious cultural and economic side effects. There is ample literature now to show that masks, as we are using them, do not work.
7) Persons who have had COVID-19 infection have a robust and long-lasting immunity. This immunity also is likely to protect against variants. As evidence continues to accumulate that the new mRNA vaccines are neither as effective nor safe as advertised, I would advise not getting the vaccine on top of your natural immunity if you had the COVID-19 infection.
8) There is very little, if any, spread of COVID-19 from asymptomatic persons. This lie was spread early to maximize fear of this new virus. COVID-19 is like other respiratory viral infections—you catch it from being around someone who has symptoms. Like other viral infections, if you are sick stay home, quarantine yourself, and treat yourself. We do not need to quarantine the asymptomatic healthy.
9) The death rate nationally for COVID-19 has been going down since January. Breathless “news” reporters talk about cases, hospital occupation, and contagiousness but never mention the death decline. There has been a small uptick in deaths in some areas over the last week, but not anywhere close to last winter. (There will be some variations in the death rate as we transition to endemic status)
10) The Delta variant is acting like a typical historical virus variant. Typically, variants happen all the time and are more contagious but less deadly. Initial reports show that this is likely true with Delta. A UK report states the Delta variant is likely 20 times less deadly than the alpha strain, but that more data needs to be collected. The media constantly mentions that delta is more contagious which is also true. Other Greek variants are likely to behave in the same fashion.
We do not need to be afraid of COVID-19 anymore. Let’s begin to end the hysteria and fear. The worst is over and we are transitioning to endemic status which means a low level of cases and deaths.
We will have many fewer deaths if we start to treat the infection early now with the available outpatient treatments. We should resist further attempts at lockdowns and mask mandates as neither worked. We know exactly whom to protect—the elderly and those with chronic health problems. That’s where we should concentrate our energies.
Thankfully, children have very little risk and do not need masks at school or vaccinations. Variants will come but will not send us back into a situation like last year.
Can our pandemic managers take some of this useful information and transform it into helpful public health policies from this point forward? Or is there another agenda behind unending hysteria, fear, and the constant push for 100% vaccination? That remains to be seen. For now, let’s celebrate the good news.’https://www.americanthinker.com/articles/2021/08/the_good_newsa_covid19_update.html
Australian politicians are talking about injecting these vaccines in the arms of those down to the age of twelve! Here ‘Stew Peters talks with former Pfizer employee and biotech analyst, Karen Kingston. Kingston reveals what the FDA approval really means, and why it’s “game over” for the vaccine manufacturer, and for the inoculation.’
Remember South Africa’s Apartheid? Well, now in New South Wales, Australia we have the Covid Health Apartheid! Our ‘leaders’ have deemed that only those who submit to the government push for these experimental vaccines may have a ‘LITTLE’ of their freedom back. So, ‘Fully vaccinated NSW residents will be able to take advantage of eased coronavirus rules from September 13.
The new rules will be different for people inside coronavirus hotspots and those outside those areas.
But in all areas, those who take advantage of the eased rules must be fully vaccinated with two doses and be able to prove their vaccination status if asked by an official.
For people outside of local government areas (LGAs) of concern, the rule changes will mean:
- Fully vaccinated people can gather outside in groups of up to five
- All those people must be vaccinated
- The gathering must take place in the people’s LGA or within 5km of home
- The limit is five individuals whether the people are children or adults
For people in LGAs of concern, the rule changes will mean:
- Fully vaccinated adults can gather outside for one hour of recreation per day
- The outdoor activity can be a picnic, not just exercise
- The rest of the restrictions still apply, meaning there’s a limit of two people unless the people gathering are all from the same household
- The one hour of recreation is in addition to the allowed one hour of exercise, meaning each person can be outside for a total of two hours in a day
- The gathering must take place outside curfew hours
The curfew in hotspot area is from 9pm to 5am.
The Sydney hotspot areas are:
- Bayside
- Blacktown
- Burwood
- Campbelltown
- Canterbury-Bankstown
- Cumberland
- Fairfield
- Georges River
- Liverpool
- Parramatta
- Strathfield
- Penrith for the following suburbs: Caddens, Claremont Meadows, Colyton, Erskine Park, Kemps Creek, Kingswood, Mount Vernon, North St Marys, Orchard Hills, Oxley Park, St Clair and St Marys.
Under the current rules, hotspot residents can only go outside for one hour of exercise.
People outside the hotspots are already allowed to go outside for recreation, but with only one other person unless they’re from the same household.
“While there are various options we looked at, that was the option that met the mental health needs and wellbeing of our community,” NSW Premier Gladys Berejiklian said.
She had previously said her government would announce eased rules for vaccinated people once the state had reached more than six million jabs.
That milestone was reached this week.
Ms Berejiklian also said there would be more rules that would ease once the state hits another target of getting 70 per cent of the population vaccinated against the coronavirus.
There would also be another set of rules that would change once an 80 per cent vaccination level was reached.
However, it wasn’t immediately clear what those rule changes would be.
“I want to strongly message today that NSW is calling on industry and citizens to get ready for when we are 70 per cent double vaccinated, that’s when things will start to open,” Ms Berejiklian said.
“The NSW government will start conversations with industry, but we do say that the condition of you participating and what will be reopening is on you being vaccinated.
“Because when you start opening at 70 per cent, there are certain activities only vaccinated people can do.”
The announcement came on another record day of coronavirus infections, with 1029 local cases.’https://www.news.com.au/national/nsw-act/news/nsw-restrictions-for-fully-vaccinated-people-all-the-changes-to-start-from-midseptember/news-story/04d878cb8e0049b4e5493869a1a4f166
‘Monday, the U.S. Food and Drug Administration (FDA) approved a biologics license application for the Pfizer Comirnaty vaccine.
The press reported that vaccine mandates are now legal for military, healthcare workers, college students and employees in many industries. New York City Mayor Bill de Blasio has now required the vaccine for all teachers and school staff. The Pentagon is proceeding with its mandate for all military service members.
But there are several bizarre aspects to the FDA approval that will prove confusing to those not familiar with the pervasiveness of the FDA’s regulatory capture, or the depths of the agency’s cynicism.
First, the FDA acknowledges that while Pfizer has “insufficient stocks” of the newly licensed Comirnaty vaccine available, there is “a significant amount” of the Pfizer-BioNTech COVID vaccine — produced under Emergency Use Authorization (EUA) — still available for use.
The FDA decrees that the Pfizer-BioNTech vaccine under the EUA should remain unlicensed but can be used “interchangeably” (page 2, footnote 8) with the newly licensed Comirnaty product.
Second, the FDA pointed out that the licensed Pfizer Comirnaty vaccine and the existing, EUA Pfizer vaccine are “legally distinct,” but proclaims that their differences do not “impact safety or effectiveness.”
There is a huge real-world difference between products approved under EUA compared with those the FDA has fully licensed.
EUA products are experimental under U.S. law. Both the Nuremberg Code and federal regulations provide that no one can force a human being to participate in this experiment. Under 21 U.S. Code Sec.360bbb-3(e)(1)(A)(ii)(III), “authorization for medical products for use in emergencies,” it is unlawful to deny someone a job or an education because they refuse to be an experimental subject. Instead, potential recipients have an absolute right to refuse EUA vaccines.
U.S. laws, however, permit employers and schools to require students and workers to take licensed vaccines.
EUA-approved COVID vaccines have an extraordinary liability shield under the 2005 Public Readiness and Preparedness Act. Vaccine manufacturers, distributors, providers and government planners are immune from liability. The only way an injured party can sue is if he or she can prove willful misconduct, and if the U.S. government has also brought an enforcement action against the party for willful misconduct. No such lawsuit has ever succeeded.
The government has created an extremely stingy compensation program, the Countermeasures Injury Compensation Program, to redress injuries from all EUA products. The program’s parsimonious administrators have compensated under 4% of petitioners to date — and not a single COVID vaccine injury — despite the fact that physicians, families and injured vaccine recipients have reported more than 600,000 COVID vaccine injuries.
At least for the moment, the Pfizer Comirnaty vaccine has no liability shield. Vials of the branded product, which say “Comirnaty” on the label, are subject to the same product liability laws as other U.S. products.
When the Centers for Disease Control and Prevention’s (CDC) Advisory Committee for Immunization Practices places a vaccine on the mandatory schedule, a childhood vaccine benefits from a generous retinue of liability protections.
But licensed adult vaccines, including the new Comirnaty, do not enjoy any liability shield. Just as with Ford’s exploding Pinto, or Monsanto’s herbicide Roundup, people injured by the Comirnaty vaccine could potentially sue for damages.
And because adults injured by the vaccine will be able to show that the manufacturer knew of the problems with the product, jury awards could be astronomical.
Pfizer is therefore unlikely to allow any American to take a Comirnaty vaccine until it can somehow arrange immunity for this product.
Given this background, the FDA’s acknowledgement in its approval letter that there are insufficient stocks of the licensed Comirnaty, but an abundant supply of the EUA Pfizer BioNTech jab, exposes the “approval” as a cynical scheme to encourage businesses and schools to impose illegal jab mandates.
The FDA’s clear motivation is to enable Pfizer to quickly unload inventories of a vaccine that science and the Vaccine Adverse Events Reporting System have exposed as unreasonably dangerous, and that the Delta variant has rendered obsolete.’https://childrenshealthdefense.org/defender/mainstream-media-fda-approval-pfizer-vaccine/
‘Pfizer CEO Albert Bourla said on Tuesday that, at some point in the future, a strain of COVID-19 that is resistant to vaccines is likely to emerge.
“Every time that the variant appears in the world, our scientists are getting their hands around it,” Bourla told Fox News in an interview. “They are researching to see if this variant can escape the protection of our vaccine. We haven’t identified any yet but we believe that it is likely that one day, one of them will emerge.”
This is not the first time Bourla has made the ominous prediction. He addressed the issue in a wide-ranging interview with Fortune in February, around the time when attention was increasingly turning to new mutations of the CCP (Chinese Communist Party) virus, the pathogen that causes COVID-19.
Responding to a question about the effectiveness of the Pfizer vaccine against emerging variants, Bourla said he was “quite confident” it could neutralize the new mutations and cited encouraging lab results. At the same time, he said that “the fundamental question” is how likely it is that there will eventually emerge a vaccine-resistant strain of coronavirus.
“Theoretically, it’s a very possible scenario. If you protect a very big part of the population, and if there is a strain that emerges that can use this pool of population to replicate while the current strains cannot, obviously this will overtake the original. So it’s not a certainty, but it is now, I believe, a likely scenario,” he said.
At the time, Bourla told Fortune that the mRNA technology used in the Pfizer-BioNTech vaccine allows for the rapid development of a new version able to create a different immunogenicity that could cover new mutations. He predicted that such a vaccine could be developed in around two months but noted this would depend on multiple factors including the regulatory framework.
In his interview with Fox News, he expanded on this, saying Pfizer has a process in place allowing the company to develop a variant-specific vaccine within 95 days of identifying a new mutation.
His remarks came on the same day that the Centers for Disease Control and Prevention (CDC) reported new data shedding more light on vaccine effectiveness against the Delta variant. Based on a study of 4,217 fully vaccinated participants—65 percent of whom received the Pfizer shot, 33 percent took Moderna’s vaccine, and 2 percent got the Johnson&Johnson jab—the CDC report found lower effectiveness (66 percent) during the Delta prominent period compared to the months preceding Delta predominance (91 percent).
A day earlier, the Food and Drug Administration (FDA) granted full regulatory approval for Pfizer’s COVID-19 vaccine for people 16 and older, making it the first such shot to make it beyond the emergency-use-only stage.’https://www.theepochtimes.com/mkt_morningbrief/pfizer-ceo-predicts-vaccine-resistant-covid-19-variant-likely-to-emerge_3963263.html?utm_source=morningbriefnoe&utm_medium=email&utm_campaign=mb-2021-08-25&mktids=eaa8fdcff4f0407d01ee4d202f3a7e63&est=2p%2FQE9kO6HazVCAkZZqv7i7C1sUxBjti4dXWGCZIsohzKTmU4KIVz%2BDjlep%2F4PuuVA%3D%3D
whatyareckon 